MELINTA Trademark

Trademark Overview

On Friday, September 13, 2013, a trademark application was filed for MELINTA with the United States Patent and Trademark Office. The USPTO has given the MELINTA trademark a serial number of 86063824. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 18, 2021. This trademark is owned by Rib-X Pharmaceuticals, Inc.. The MELINTA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery services; research and development of antibiotics
melinta

General Information

Serial Number86063824
Word MarkMELINTA
Filing DateFriday, September 13, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 18, 2021
Registration Number4653983
Registration DateTuesday, December 9, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2014

Trademark Statements

Goods and Servicesdrug discovery services; research and development of antibiotics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 20, 2013
Primary Code042
First Use Anywhere DateMonday, October 7, 2013
First Use In Commerce DateMonday, October 7, 2013

Trademark Owner History

Party NameMELINTA SUBSIDIARY CORP.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressParsippany, NJ 06511
Party NameMELINTA THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 06511
Party NameMELINTA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 06511
Party NameMELINTA THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 06511
Party NameRib-X Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511

Trademark Events

Event DateEvent Description
Thursday, December 26, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2013NEW APPLICATION ENTERED
Friday, September 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 27, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, December 25, 2013ASSIGNED TO EXAMINER
Tuesday, November 4, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 15, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2014PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 29, 2014TEAS STATEMENT OF USE RECEIVED
Monday, September 29, 2014USE AMENDMENT FILED
Thursday, October 16, 2014STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 14, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 3, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 30, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 9, 2014REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 9, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, January 13, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, March 18, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, August 22, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, December 9, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, March 18, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 18, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

melinta development antibiotics research services discovery drug